Today’s decentralized and virtual trials require a shift to direct-to-patient (DTP) distribution to keep trials moving forward. Join this webinar to explore opportunities to optimize a supply chain strategy that accommodates both direct-to-site and direct-to-patient services utilizing a global Good Manufacturing Practices (GMP) depot network along with DTP and direct-from-patient (DFP) services.
DTP services improve patient retention and engagement. Storing clinical drug products and supplies geographically closer to patients or sites can help mitigate the risk of products becoming damaged in transport, as well as avoiding trial disruptions and minimizing delays due to import regulations.
Join Marken’s experts as we explore opportunities to optimize your supply chain strategy to facilitate both direct-to-site and direct-to-patient services utilizing a global GMP depot network. Learn the keys to successfully navigating critical paths, including project management, set-up processes, and risk assessment to drive your trial forward.
Reserve your free spot.
Nina Vas, Vice President, Clinical Distribution, Cell & Gene Supply Chain, Marken
Nina Vas is Marken’s Vice President, Clinical Distribution, Cell & Gene Supply Chain and focuses on leading Marken’s global GMP depot network as well as its fast-growing cell and gene division. She oversees their global network of liquid nitrogen storage facilities and Marken’s designated Centers of Excellence for cell and gene therapy logistics across the U.S., Europe, and Asia. She brings financial, operational, quality and process improvement experience to managing the performance of the full supply chain and supporting the execution of distribution for clinical trials to global destinations. Her background includes importing and exporting of drug product (from API to finished goods and ancillaries) with Clinical Research Organizations, Pharmaceutical Importers, owned facilities and third‐party depots. Nina previously served as Managing Director for one of the largest CMOs in the industry.Message Presenter
Gaurang Majmudar, Senior Director, Global Patient Centric Services, Marken
As senior director, Global Patient Centric Services at Marken, Gaurang is responsible for overseeing the expansion of patient centric services in the EMEA and APAC regions and the development of new service offerings for our clients to further expand and streamline the clinical trial experience for patients and sponsors.
Gaurang offers a wealth of experience from the pharmaceutical, distribution, and home healthcare industries. He has held senior marketing and commercial roles within pharmaceutical companies, where he was responsible for product development and launches within specialty medicines and orphan diseases sectors.
Prior to Marken, Gaurang worked with Walgreens Boots Alliance (WBA), where he was responsible for the development of their patient services offering across Europe and other global locations. He led the launch of the WBA Alcura business across six markets in the EU including patient services and clinical trials support. In other roles, he has advised and led global pharma teams focused on patient centric services and implemented patient support programs (PSPs) for specialty medicines.Message Presenter
Who Should Attend?
- Pharmaceutical Companies
- Biotechnology Companies
- Central Labs
What You Will Learn
In this webinar, participants will learn about:
- Optimizing your supply chain with visibility and success.
- Avoiding pitfalls when switching providers to meet the needs of your full trial ecosystem.
- Ensuring quality and on-time performance to help next-generation treatments, therapies, and cures come to market.
Marken is a wholly owned subsidiary of the UPS Healthcare division. With Polar Speed and Marken included, the UPS Healthcare division staffs 128 locations with 5,500 employees worldwide. Marken offers a state-of-the-art GMP-compliant depot network and logistic hubs for clinical drug product storage and distribution in 56 locations worldwide, while maintaining the leading position for direct-to-patient and home healthcare services, biological sample shipments, and biological kit production. Marken’s dedicated 1,600 staff members manage 100,000 drug product and biological sample shipments every month at all temperature ranges in more than 220 countries. Additional services such as ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory, and compliance consultancy add to Marken’s unique position in the pharma and logistics industry.